{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:03Z","timestamp":1790341983429,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amyotrophic Lateral Sclerosis (ALS) is a rare, progressive, and fatal neurodegenerative disease due to upper and lower motor neuron involvement with symptoms classically occurring in adulthood with an increasing recognition of juvenile presentations and childhood neurodegenerative disorders caused by genetic variants in genes related to Amyotrophic Lateral Sclerosis. The main objective of this study is detail clinical, radiological, neurophysiological, and genetic findings of a Brazilian cohort of patients with a recent described condition known as Spastic Tetraplegia and Axial Hypotonia (STAHP) due to SOD1 deficiency and compare with other cases described in the literature and discuss whether the clinical picture related to SOD1 protein deficiency is a new entity or may be represent a very early-onset form of Amyotrophic Lateral Sclerosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a case series report which included retrospective data from five Brazilian patients with SOD1 protein deficiency of a Brazilian reference center for Neuromuscular Disorders. Clinical data were obtained from a review of the medical records and descriptive statistics and variables were summarized using counts and percentages of the total population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All 5 patients presented with a childhood-onset neurodegenerative disorders characterized by spastic tetraplegia with axial hypotonia in all cases, with gestational history showing polyhydramnios in 4\/5 and intrauterine growth restriction in 3\/5 patients, with most patients initially presenting a normal motor development until the six month of life or during the first year followed by a rapidly progressive motor decline with severe dysphagia and respiratory insufficiency in all patients accompanied by cognitive impairment in 3\/5 patients. All patients were homozygous for the c.335dupG (p.Cys112Trpfs*11) mutation in the <jats:italic>SOD1<\/jats:italic> gene with completely decreased enzyme activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case series is the biggest data collection of the new recent clinical entity described as Spastic Tetraplegia and Axial Hypotonia (STAHP) due to SOD1 deficiency.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01993-0","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T21:02:46Z","timestamp":1628715766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-7108","authenticated-orcid":false,"given":"Paulo Victor Sgobbi","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimir Bocca Vieira de Rezende","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Braga","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno de Mattos Lombardi","family":"Badia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icaro Fran\u00e7a Navarro","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Carvalho","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Maria","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"dos Santos Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00edlia Correia","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo de Lima","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Ismael Lacerda","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Ant\u00f4nio Troccoli","family":"Chieia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acary Souza Bulle","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"publisher","first-page":"108701","DOI":"10.1016\/j.abb.2020.108701","volume":"697","author":"ECA Eleutherio","year":"2021","unstructured":"Eleutherio ECA, Magalh\u00e3es RSS, Brasil AA, Neto JRM, Paranhos LH. SOD1, more than just an antioxidant. Arch Biochem Biophys. 2021;697:108701.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"1993_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","volume":"577","author":"SJ Kaur","year":"2016","unstructured":"Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene. 2016;577(2):109\u201318.","journal-title":"Gene"},{"issue":"6415","key":"1993_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Henati A, et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59\u201362.","journal-title":"Nature"},{"issue":"12","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1590\/0004-282X20150161","volume":"73","author":"PVS Souza","year":"2015","unstructured":"Souza PVS, Pinto WBVR, Chieia MAT, Oliveira ASB. Clinical and genetic basis of familial amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2015;73(12):1026\u201337.","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"1993_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/NEJMc1905039","volume":"381","author":"PM Andersen","year":"2019","unstructured":"Andersen PM, Nodrstr\u00f6m U, Tsiakas K, Johannsen J, Volk AE, Bierhals T, et al. Phenotype in an infant with SOD1 homozygous truncating mutation. N Engl J Med. 2019;381(5):486\u20138.","journal-title":"N Engl J Med"},{"issue":"8","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/brain\/awz182","volume":"142","author":"JH Park","year":"2019","unstructured":"Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, et al. SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019;142(8):2230\u20137.","journal-title":"Brain"},{"issue":"4","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neurol.2018.04.010","volume":"175","author":"WBVR Pinto","year":"2019","unstructured":"Pinto WBVR, Naylor FGM, Chieia MAT, Souza PVS, Oliveira ASB. New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome. Rev Neurol (Paris). 2019;175(4):238\u201346.","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361\u20132.","journal-title":"Nat Methods"},{"issue":"4","key":"1993_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Seelow D. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"1","key":"1993_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0003-2697(89)90192-9","volume":"179","author":"DR Spitz","year":"1989","unstructured":"Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem. 1989;179(1):8\u201318.","journal-title":"Anal Biochem"},{"key":"1993_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/0471140856.tx0705s08","author":"DR Spitz","year":"2001","unstructured":"Spitz DR, Oberley LW. Measurement of MnSOD and CuZnSOD activity in mammalian tissue homogenates. Curr Protoc Toxicol. 2001. https:\/\/doi.org\/10.1002\/0471140856.tx0705s08.","journal-title":"Curr Protoc Toxicol"},{"issue":"4","key":"1993_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ana.410220409","volume":"22","author":"S DiMauro","year":"1987","unstructured":"DiMauro S, Serviei S, Zeviani M, DiRocco M, DeVivo DC, DiDonato S, et al. Cytochrome c oxidase deficiency in Leigh Syndrome. Ann Neurol. 1987;22(4):498\u2013506.","journal-title":"Ann Neurol"},{"issue":"10107","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldnik JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084\u201398.","journal-title":"Lancet"},{"issue":"1","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chi\u00f2 A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94\u2013102.","journal-title":"Lancet Neurol"},{"key":"1993_CR15","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1993_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/0004-282X20140229","volume":"73","author":"PV Souza","year":"2015","unstructured":"Souza PV, Pinto WB, Oliveira AS. C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases. Arq Neuropsiquiatr. 2015;73(3):246\u201356.","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"1993_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1\u20132 trial of antisense oligonuleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109\u201319.","journal-title":"N Engl J Med"},{"issue":"2","key":"1993_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMoa2005056","volume":"383","author":"C Mueller","year":"2020","unstructured":"Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, et al. SOD1 suppression with adeno-associated virus and MicroRNA in familial ALS. N Engl J Med. 2020;383(2):151\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"1993_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/ijms19051345","volume":"19","author":"O Pansarasa","year":"2018","unstructured":"Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. SOD1 in amyotrophic lateral sclerosis: \u201cambivalent\u201d behavior connected to the disease. Int J Mol Sci. 2018;19(5):1345.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1074\/jbc.M209915200","volume":"278","author":"S Allen","year":"2003","unstructured":"Allen S, Heath PR, Kirby J, et al. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant, defenses, and nitric oxide synthetic pathways. J Biol Chem. 2003;278(8):6371\u201383.","journal-title":"J Biol Chem"},{"issue":"22","key":"1993_CR21","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","volume":"16","author":"KJ De Vos","year":"2007","unstructured":"De Vos KJ, Chapman AL, Tennant ME, Wharton SB, Cookson MR, Menzies FM, et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet. 2007;16(22):2720\u20138.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7(9):710\u201323.","journal-title":"Nat Rev Neurosci"},{"key":"1993_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0072-9752(07)80018-2","volume":"82","author":"P Orban","year":"2007","unstructured":"Orban P, Devon RS, Hayden MR, Leavitt BR. Chapter 15 Juvenile amyotrophic lateral sclerosis. Handb Clin Neurol. 2007;82:301\u201312.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"1993_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cge.13015","volume":"92","author":"Z-J Liu","year":"2017","unstructured":"Liu Z-J, Lin H-X, Liu G-L, Tao Q-Q, Ni W, Xiao B-G, et al. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet. 2017;92(3):267\u201373.","journal-title":"Clin Genet"},{"issue":"4","key":"1993_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neurol.2018.04.016","volume":"175","author":"WBVR Pinto","year":"2019","unstructured":"Pinto WBVR, Debona R, Nunes PP, Assis ACD, Lopes CG, Bortholin T, et al. Atypical motor neuron disease variants: still a diagnostic challenge in neurology. Rev Neurol (Paris). 2019;175(4):221\u201332.","journal-title":"Rev Neurol (Paris)"},{"issue":"8","key":"1993_CR26","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.clinph.2020.04.012","volume":"131","author":"B Jonhsen","year":"2020","unstructured":"Jonhsen B. Diagnostic criteria for amyotrophic lateral sclerosis from EL escorial to gold coast. Clin Neurophysiol. 2020;131(8):1962\u20133.","journal-title":"Clin Neurophysiol"},{"issue":"8","key":"1993_CR27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975\u20138.","journal-title":"Clin Neurophysiol"},{"issue":"10","key":"1993_CR28","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.clinph.2018.07.015","volume":"129","author":"J Tsugawa","year":"2018","unstructured":"Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC. Fasciculation intensity and disease progression in amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129(10):2149\u201354.","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"1993_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrneurol.2011.151","volume":"7","author":"R Bowser","year":"2011","unstructured":"Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol. 2011;7(11):631\u20138.","journal-title":"Nat Rev Neurol"},{"key":"1993_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.WNP.0000151146.91147.A1","volume":"22","author":"M Hellmann","year":"2005","unstructured":"Hellmann M, von Kleist-Retzow JC, Haupt WF, Herkenrath P, Schauseil-Zipf U. Diagnostic value of electromyography in children and adolescents. J Clin Neurophysiol. 2005;22:43\u20138.","journal-title":"J Clin Neurophysiol"},{"issue":"12","key":"1993_CR31","first-page":"1057","volume":"136","author":"RJ Packer","year":"1982","unstructured":"Packer RJ, Brown MJ, Berman PH. The diagnostic value of electromyography in infantile hypotonia. Am J Dis Child. 1982;136(12):1057\u20139.","journal-title":"Am J Dis Child"},{"key":"1993_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.rehab.2009.06.004","volume":"52","author":"E Cetin","year":"2009","unstructured":"Cetin E, Cuisset JM, Tiffreau V, Vall\u00e9e L, Hurtevent JF, Thevenon A. The value of electromyography in the aetiological diagnosis of hypotonia in infants and toddlers. Ann Phys Rehabil Med. 2009;52:546\u201355.","journal-title":"Ann Phys Rehabil Med"},{"issue":"2","key":"1993_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.10850","volume":"55","author":"PM Andersen","year":"2004","unstructured":"Andersen PM, Restagno G, Stewart HG, Chi\u00f2 A. Disease penetrance in amyotrophic lateral sclerosis associated with mutations in the SOD1 gene. Ann Neurol. 2004;55(2):298\u20139.","journal-title":"Ann Neurol"},{"issue":"Pt 8","key":"1993_CR34","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1093\/brain\/awt097","volume":"136","author":"RA Saccon","year":"2013","unstructured":"Saccon RA, Bunton-Stasyshyn RH, Fisher EM, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136(Pt 8):2342\u201358.","journal-title":"Brain"},{"issue":"4","key":"1993_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13760-019-01160-0","volume":"119","author":"M Mastrangelo","year":"2019","unstructured":"Mastrangelo M. Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta Neurol Belg. 2019;119(4):511\u201321.","journal-title":"Acta Neurol Belg"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01993-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T21:04:58Z","timestamp":1628715898000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01993-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01993-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"20 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval of this study is covered by the institutional ethics committee (CAAE: 93830518.5.0000.5505). Consent for publication was obtained from all participants\/caregivers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the patients or caregivers gave written informed consent to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}